Read more about the article Cilcare Awarded €4.2 million to combat the global epidemic of hidden hearing loss, as part of the France 2030 Plan’s “i-Démo” call for projects
Cilcare awarded €4.2 million with i-Démo call for projects

Cilcare Awarded €4.2 million to combat the global epidemic of hidden hearing loss, as part of the France 2030 Plan’s “i-Démo” call for projects

Through the ‘i-Démo’ call for projects under the France 2030 plan, operated by Bpifrance on behalf of the French government, Cilcare is further consolidating its international leadership by being the…

Continue ReadingCilcare Awarded €4.2 million to combat the global epidemic of hidden hearing loss, as part of the France 2030 Plan’s “i-Démo” call for projects
Read more about the article Cilcare and Shionogi announce exclusive Option Agreement for innovative hearing disorder treatment
Shionogi Cilcare agreement

Cilcare and Shionogi announce exclusive Option Agreement for innovative hearing disorder treatment

Montpellier and Osaka – June 6th, 2024 – Cilcare, a leading biotech company specializing in auditory sciences, is pleased to announce a landmark agreement with Shionogi, an impact-driven pharmaceutical company.…

Continue ReadingCilcare and Shionogi announce exclusive Option Agreement for innovative hearing disorder treatment